Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: If PTSC owned half the license - the the 3.5% should come only from TPL...
I would be relieved if that is the case and I misinterpreted the legal filing. I'll have to reread Laurie's link as I rushed through it.
Share
New Message
Please login to post a reply